Advertisement
Singapore markets close in 3 hours 53 minutes
  • Straits Times Index

    3,168.91
    -18.75 (-0.59%)
     
  • Nikkei

    37,113.03
    -966.67 (-2.54%)
     
  • Hang Seng

    16,184.02
    -201.85 (-1.23%)
     
  • FTSE 100

    7,877.05
    +29.06 (+0.37%)
     
  • Bitcoin USD

    62,325.06
    +593.74 (+0.96%)
     
  • CMC Crypto 200

    1,288.44
    +402.90 (+44.35%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,398.40
    +0.40 (+0.02%)
     
  • Crude Oil

    84.25
    +1.52 (+1.84%)
     
  • 10-Yr Bond

    4.6470
    +0.0620 (+1.35%)
     
  • FTSE Bursa Malaysia

    1,551.42
    +6.66 (+0.43%)
     
  • Jakarta Composite Index

    7,063.10
    -103.72 (-1.45%)
     
  • PSE Index

    6,411.73
    -111.46 (-1.71%)
     

Is AbbVie or Amgen the Better Bargain Buy Right Now?

Is AbbVie or Amgen the Better Bargain Buy Right Now?

Due to the highly competitive nature of the pharmaceutical industry, it is no easy task to replace the aging stars in a drug portfolio. Teva Pharmaceutical (NYSE: TEVA) illustrates this point nicely. In the middle of the last decade, Teva lost exclusivity for its multiple sclerosis medication Copaxone.